Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Crescita Therapeutics Inc
(OP:
CRRTF
)
0.3901
UNCHANGED
Last Price
Updated: 10:03 AM EST, Feb 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Crescita Therapeutics Inc
Crescita Reports Q4 and Fiscal 2024 Results
March 18, 2025
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Third Quarter 2024 Results
November 06, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
September 24, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024
September 12, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Second Quarter 2024 Results
August 07, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years
July 22, 2024
From
Crescita Therapeutics
Via
Business Wire
Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
July 19, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device
July 17, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
June 26, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita to Acquire Strategic Assets of Occy Laboratory
June 20, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports First Quarter 2024 Results
May 08, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Q4 and Fiscal 2023 Results
March 13, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Third Quarter 2023 Results
November 08, 2023
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
August 29, 2023
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Second Quarter 2023 Results
August 09, 2023
From
Crescita Therapeutics
Via
Business Wire
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
June 21, 2023
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports First Quarter 2023 Results
May 11, 2023
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Reports Q4 and Fiscal 2022 Results
March 15, 2023
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Reports Third Quarter 2022 Results
November 09, 2022
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Reports Second Quarter 2022 Results
August 10, 2022
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
May 12, 2022
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports First Quarter 2022 Results
May 11, 2022
From
Crescita Therapeutics
Via
Business Wire
Crescita to Present at Bloom Burton & Co. Healthcare Investor Conference
April 21, 2022
From
Crescita Therapeutics
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
